Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)

201467 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Cancer Chemotherapy and Pharmacology

Volume 74, Issue 2, pp. 379-387

Field-Weighted Citation Impact: 3.58